background image

Lung Cancer Clinical Trials

Find clinical trials for lung cancer. Search for lung cancer clinical trials in different cities and states across the United States.

Filter
1
Active & Responsive

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

for
Small Cell Lung Cancer
Location: Miami FL, Chicago IL, Boston MA, Hackensack NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06780137

Phase1, Phase2, Recruiting
Active & Responsive

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

for
Lung Cancer, Breast Cancer
Location: Miami FL, Hackensack NJ, Cleveland OH, Seattle WA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06618287

Phase1, Phase2, Recruiting
Active & Responsive

WTC Chest CT Imaging Archive

for
Chronic Airway Disease, Interstitial Lung Disease, Lung Cancer
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT03295279

Recruiting
Active & Responsive

A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)

for
Lung Cancer, Non-Small Cell Lung Cancer
Location: Fullerton CA, Peoria IL, The Bronx NY, Cincinnati OH
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06698042

Phase3, Recruiting
Active & Responsive

Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer

for
NSCLC, NSCLC Stage IV, NSCLC Stage IIIB,
Location: La Jolla CA, Los Angeles CA, Newport Beach CA,
Sponsor: Mythic Therapeutics

Sex: All

Age: 18+

Code: NCT05652868

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Duarte CA, Glendale CA, Los Angeles CA, Murrieta CA,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 18+

Code: NCT04198766

Phase1, Phase2, Recruiting
Active & Responsive

Study of XB010 in Subjects With Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors,
Location: Duarte CA, Washington D.C. DC, St Louis MO,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06545331

Phase1, Recruiting
Active & Responsive

Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: Santa Rosa CA, Hartford CT, Washington D.C. DC,
Sponsor: VM Oncology, LLC

Sex: All

Age: 18 - 70+

Code: NCT03556228

Phase1, Recruiting
Active & Responsive

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Orange CA, Santa Monica CA, Tampa FL, Baltimore MD,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT05379985

Phase1, Recruiting
Active & Responsive

A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

for
Advanced Solid Tumor, Locally Advanced Solid Tumor,
Location: Los Angeles CA, Springfield IL, Louisville KY,
Sponsor: Ascendis Pharma Oncology Division A/S

Sex: All

Age: 18+

Code: NCT05081609

Phase1, Phase2, Recruiting